Encouragingly, we found that the resultant fusion protein TGFαL3SEAD227A could bind to EGFR-expressing tumour cells and exhibited an apparent growth inhibitory effect on the tumour cells, both in vitro and in vivo. The gene discussed is EGFR; the disease is neoplasm.